Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.

New York's Neediest Get Health Care Delivered In The Streets, Courtesy Of Project Renewal 'carevans' - Am New York

Human tape worm drug shows promise against MRSA in lab -- ScienceDaily

Mullen came in worried about his liver enzymes, which were slightly elevated, but LaRock also took the opportunity to discuss the importance of Mullen quitting cigarettes. Quitting, Mullen finally acknowledged, "is just a matter of doing it." (Credit: Sheila Anne Feeney) http://www.amny.com/lifestyle/new-york-s-neediest-get-health-care-delivered-in-the-streets-courtesy-of-project-renewal-carevans-1.10310711 Nurse practitioner Bill LaRock tells Sean Mullen that he should consider treatment for his hepatitis http://cdn.newsday.com/polopoly_fs/1.10304515.1429551790!/httpImage/image.JPG_gen/derivatives/display_600/image.JPG
For the original version including any supplementary images or video, visit http://www.amny.com/lifestyle/new-york-s-neediest-get-health-care-delivered-in-the-streets-courtesy-of-project-renewal-carevans-1.10310711

New Data Shows Greater In Vitro Potency for VIBATIV(R) (Telavancin) Against Multidrug-Resistant Gram-Positive Bacteria, Including MRSA, Compared to Alternative Antibiotic Treatments - Yahoo Finance

The material above is intended for legitimate news entities only; it may not be used for advertising or promotional purposes. Consumer Reports is an expert, independent nonprofit organization whose mission is to work for a fair, just, and safe marketplace for all consumers and to empower consumers to protect themselves. We accept no advertising and pay for all the products we test. We are not beholden to any commercial interest. Our income is derived from the sale of Consumer Reports, ConsumerReports.org and our other publications and information products, services, fees, and noncommercial contributions and grants. Our Ratings and reports are intended solely for the use of our readers.
For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/04/prweb12677887.htm

That might limit the toxicity of the drug, and until it is tested, it's not clear that quick clearance would undermine the drug's performance against MRSA. "Remember that no one has ever tested niclosamide for treating bacterial infections," he said. If niclosamide, which is already used in humans for one purpose, can also help them fight off a superbug, or if its apparently more effective and less toxic cousin oxyclozanide can gain approval for human use, doctors could obtain much needed ammunition against MRSA. "The relatively mild toxicity of oxyclozanide is encouraging based on in vitro tests," Rajamuthiah said. "Since it has never been tested in humans and since it belongs to the same structural family as niclosamide, our findings give strong impetus to using oxyclozanide for further investigations." Particularly important is that because oxyclozanide attacks the cell membrane instead of metabolic pathways, it may be more difficult for MRSA to develop resistance, Rajamuthiah said. In addition to Rajamuthiah, the paper's other authors are senior and corresponding author Dr. Eleftherios Mylonakis, Beth Burgwyn Fuchs, Elamparithi Jayamani, Bumsup mrsa skin Kwon, and http://mrsasolution.info/mrsa-skin-infection-nose/ Wooseong Kim, all of Brown University and Rhode Island Hospital, and Annie L. Conery, and Frederick M.
For the original version including any supplementary images or video, visit http://www.sciencedaily.com/releases/2015/04/150423130213.htm

Basilea reports isavuconazole and ceftobiprole data to be presented at ECCMID - Yahoo Finance

"The main source of kidney donation is the live donation and it's the best outcome," said Dr. Najjar. Dr. Najjar shows on a diagram how kidney donations are done. "They will cut the vein, the artery, and the ureter, and they will wash it and then they will put it into the patient closest to the bladder," said Dr. Najjar. For Thad the surgery was painful but the recovery process pretty quick. "Six weeks I felt like I could go back to doing things that I could go back to exercising normal," said Penrod.
For the original version including any supplementary images or video, visit http://www.good4utah.com/story/d/story/two-springville-men-take-love-thy-neighbor-literal/20186/SIbLspoQrUWETtqHQtExBg

Consumer Reports Finds Potentially Harmful Bacteria And Antibiotic Residues In Tests Of Frozen Shrimp

In addition, VIBATIV is approved in the U.S. for the treatment of adult patients with complicated skin & skin structure infections (cSSSI) caused by susceptible isolates of Gram-positive bacteria, including Staphylococcus aureus, both methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains. Theravance Biopharma plans to market VIBATIV in markets outside the United States where the drug is approved through a network of partners.To date, the company has secured partners for VIBATIV in the following geographies - Europe, Canada, Middle East, North Africa, Israel, and Russia. In Europe, VIBATIV is indicated for the treatment of adults with nosocomial pneumonia (NP) including ventilator associated pneumonia, known or suspected to be caused by MRSA. VIBATIV should be used only in situations where it is known or suspected that other alternatives are not suitable.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/data-shows-greater-vitro-potency-000100380.html

Two Springville men take 'Love Thy Neighbor' literally - Good4Utah.com

A. Cornely, N. Azie, A. Kaufhold, M. Engelhardt, J.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/basilea-reports-isavuconazole-ceftobiprole-data-051811249.html

Don't be the product, buy the product!